Type 2 Diabetes Mellitus Completed Phase 3 Trials for Metformin (DB00331)

Also known as: Diabetes Mellitus Non-insulin-dependent / Type-2 Diabetes Mellitus / Diabetes Mellitus Type 2 (T2DM) / Diabetes Mellitus Type-2 / Type 2 Diabetes (T2DM) / Diabetes, Type 2 / Diabetes Mellitus, Type 2 (T2DM) / Diabetes Mellitus,Type 2 / Diabetes Type II / Type-II Diabetes Mellitus / Diabetes Mellitus 2 Type / T2DM / Diabetes Mellitus Type II / Type II Diabetes / Diabetes Mellitus, Type 2 / Type 2 Diabetes Mellitus (T2DM) / Diabetes Type Two / Diabetes Mellitus - Type 2 / Diabetes, Type II / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus. Type 2 / Diabetes Type 2 / Type 2 Diabetes Mellitus (T2D) / Type 2 Diabetes (T2D) / Type II; Diabetes / Type II Diabetes Mellitus / Diabetes Mellitus, Type II / NIDDM / Type-2 Diabetes / Type 2 Diabetes Mellitus(T2DM) / Type 2 Diabetes / Type 2-diabetes / Noninsulin Dependent Diabetes Mellitus, Type II / Diabetes Mellitus Type 2 / Type Two Diabetes Mellitus / T2DM (Type 2 Diabetes Mellitus) / Type-2-diabetes Mellitus / Diabetes mellitus -adult onset / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00069836Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.Treatment
NCT00359112AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 DiabetesTreatment
NCT01353391Metformin in Women With Type 2 Diabetes in Pregnancy TrialTreatment
NCT01779375RISE Pediatric Medication StudyTreatment
NCT01755468Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)Treatment
NCT01841697Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)Treatment
NCT02827903Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and DyslipidemiaTreatment
NCT01386671Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 DiabetesTreatment
NCT00374907A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseTreatment
NCT01095666A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin AloneTreatment
NCT00528372A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and ExerciseTreatment
NCT00528879A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin AloneTreatment
NCT0057558852-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension PeriodTreatment
NCT00643851An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release TabletsTreatment
NCT00660907Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes PatientsTreatment
NCT00661362Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 DiabetesTreatment
NCT00683657Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR AloneTreatment
NCT00680745Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes PatientsTreatment
NCT00918138Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mgTreatment
NCT00960076An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 DiabetesTreatment
NCT01034111A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)Treatment
NCT01037842Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes MellitusTreatment
NCT01095653A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and ExerciseTreatment
NCT01204775Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 DiabetesTreatment
NCT01217892Evaluation of Dapagliflozin Taken Twice-dailyTreatment
NCT01606007Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 DiabetesTreatment
NCT01619059Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 DiabetesTreatment
NCT01624259A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 DiabetesTreatment
NCT01646320Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 DiabetesTreatment
NCT01768559Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic PatientsTreatment
NCT01822548Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 DiabetesTreatment
NCT02058160Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 DiabetesTreatment
NCT02058147Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DMTreatment
NCT03332771Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Subjects With Type 2 Diabetes Mellitus That Are Taking Metformin MonotherapyTreatment
NCT01234649Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)Prevention
NCT02787551Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension PeriodTreatment
NCT03066830Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With MetforminTreatment
NCT02926950Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of MetforminTreatment
NCT01135433A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic PatientsTreatment
NCT01999218Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)Treatment
NCT02791490A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)Treatment
NCT02738879Randomized Sitagliptin Withdrawal Study (MK-0431-845)Treatment
NCT02551874A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on MetforminTreatment
NCT02630706A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)Treatment
NCT02532855A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)Treatment
NCT02924064Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes MellitusTreatment
NCT01648582A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes MellitusTreatment
NCT02752412Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic DrugsTreatment
NCT01462266Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)Treatment
NCT01545388Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)Treatment
NCT01590771A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)Treatment
NCT01590797A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)Treatment
NCT01682759A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)Treatment
NCT01717313A Study to Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)Treatment
NCT01702298A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)Treatment
NCT01704261Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)Treatment
NCT01755156A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)Treatment
NCT02033889A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).Treatment
NCT02036515Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)Treatment
NCT02099110Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)Treatment
NCT02597049A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes MellitusTreatment
NCT02831361Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)Treatment
NCT02273050Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic ControlTreatment
NCT00856284Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes MellitusTreatment
NCT02104804Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic ControlTreatment
NCT01958671A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)Treatment
NCT02794792A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on MetforminTreatment
NCT01233622Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus GlimepirideTreatment
NCT00032487Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)Treatment
NCT00097500Effects of Exenatide and Insulin Glargine in Subjects With Type 2 DiabetesTreatment
NCT00103857MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)Treatment
NCT00131664Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)Treatment
NCT00353691Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes MellitusTreatment
NCT00350779Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)Treatment
NCT00375388The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled TrialTreatment
NCT00449930Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)Treatment
NCT00482729MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)Treatment
NCT00541775Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)Treatment
NCT00541450A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)Treatment
NCT00532935MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)Treatment
NCT00570739Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.Treatment
NCT00676338Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)Treatment
NCT00722371MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)Treatment
NCT00813995A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)Treatment
NCT00855166Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 DiabetesTreatment
NCT00859898Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesTreatment
NCT00885378Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes MellitusTreatment
NCT00885352Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)Treatment
NCT00924573Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of GlimepirideTreatment
NCT00960661A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 DiabetesTreatment
NCT0097528624-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin GlargineTreatment
NCT0097693724-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 YearsTreatment
NCT0102839130-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)Treatment
NCT01076075A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)Treatment
NCT01076088Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)Treatment
NCT01169779Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by MetforminTreatment
NCT01340768Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)Treatment
NCT01457911Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With MetforminTreatment
NCT01517412Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on MetforminTreatment
NCT01555164A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin AloneTreatment
NCT01699932Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately ControlledTreatment
NCT01787396Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.dTreatment
NCT02068443Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise TherapyTreatment
NCT02343926Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With MetforminTreatment
NCT00337610Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes MellitusTreatment
NCT01871558Vildagliptin/Metformin in T2DM Patients Starting Basal InsulinTreatment
NCT02752113Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 DiabetesTreatment
NCT01871415A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin MonotherapyTreatment
NCT01691846A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin AloneTreatment
NCT00744367A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.Treatment
NCT00755287A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.Treatment
NCT00754988A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.Treatment
NCT00763815GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of PioglitazoneTreatment
NCT03349684Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure PatientsTreatment
NCT02964247LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.Treatment
NCT01541215Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 DiabetesTreatment
NCT03268005Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 DiabetesTreatment
NCT01392573A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 DiabetesTreatment
NCT01952145A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes MellitusTreatment
NCT00067951A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II DiabeticsTreatment
NCT00499707Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes SubjectsTreatment
NCT00279045Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/GlibenclamideTreatment
NCT00121641Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseTreatment
NCT00121667Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin AloneTreatment
NCT00490178Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and DyslipidemiaTreatment
NCT00383578Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 DiabetesTreatment
NCT00399711Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 DiabetesTreatment
NCT00396357Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin AloneTreatment
NCT00798161Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial DesignTreatment
NCT00598793Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD TherapyTreatment
NCT00968812CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus GlimepirideTreatment
NCT00712673GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of MetforminTreatment
NCT00713830GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of SulfonylureaTreatment
NCT00728351Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)Treatment
NCT00715624GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal InsulinTreatment
NCT01204294Comprehensive Add on Study in JapanTreatment
NCT01106625The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)Treatment
NCT01106690The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)Treatment
NCT01381900A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a SulphonylureaTreatment
NCT01368081Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes MellitusTreatment
NCT01296412Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)Treatment
NCT00783744Insulin Glargine Combination Therapies in Type II DiabeticsTreatment
NCT00614120Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 DiabetesTreatment
NCT01459809Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes PatientsTreatment
NCT01434186A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin AloneTreatment
NCT01064687A Study in Participants With Type 2 Diabetes MellitusTreatment
NCT01106677The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)Treatment
NCT01137812The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)Treatment
NCT00915772Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg BidTreatment
NCT00789191Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 DiabetesTreatment
NCT00379769RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in DiabetesTreatment
NCT00000620Action to Control Cardiovascular Risk in Diabetes (ACCORD)Prevention
NCT03088670Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients.Treatment
NCT00382096Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 DiabetesTreatment
NCT00102466Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 DiabetesTreatment
NCT00627445Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 DiabetesTreatment
NCT00468039A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus MetforminTreatment
NCT00856986The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 DiabetesTreatment
NCT00851903Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension TrialTreatment
NCT00849056Safety and Efficacy of Albiglutide in Type 2 DiabetesTreatment
NCT00838903Efficacy and Safety of Albiglutide in Treatment of Type 2 DiabetesTreatment
NCT00839527A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 DiabetesTreatment
NCT02152371A Study of Dulaglutide (LY2189265) in Participants With Type II DiabetesTreatment
NCT01719003Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 DiabetesTreatment
NCT01023581Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesTreatment
NCT01708902Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 PatientsTreatment
NCT00295633A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy AloneTreatment
NCT00318461To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given TogetherTreatment
NCT00331851Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesTreatment
NCT00332488Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 DiabetesTreatment
NCT00333151Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesTreatment
NCT00174642Opposing Step-by-step Insulin Reinforcement to Intensified StrategyTreatment
NCT00184574Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 DiabetesTreatment
NCT00272064ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus.Treatment
NCT00097279Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 DiabetesTreatment
NCT00086502Pioglitazone Add-on Study in Patients With Type 2 Diabetes MellitusTreatment
NCT00087516Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)Treatment
NCT00099866Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 DiabetesTreatment
NCT01075282A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)Treatment
NCT00106340Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 DiabetesTreatment
NCT01126580A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)Treatment
NCT00700817The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes MellitusTreatment
NCT00707031GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of MetforminTreatment
NCT00763451GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of MetforminTreatment
NCT01809327A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and ExerciseTreatment
NCT01289119Efficacy and Safety of Alogliptin in Participants With Type 2 DiabetesTreatment
NCT02586129Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II DiabetesTreatment
NCT01505426A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes PatientsTreatment
NCT00081328Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)Treatment
NCT00086515Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)Treatment